148 related articles for article (PubMed ID: 3492836)
1. [Osteocalcin and bone metabolism in rheumatoid arthritis and osteoarthritis].
Franck H; van Valen F; Keck E; Krüskemper HL
Z Rheumatol; 1986; 45(5):241-6. PubMed ID: 3492836
[TBL] [Abstract][Full Text] [Related]
2. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
[TBL] [Abstract][Full Text] [Related]
3. Biochemical markers of bone turnover in rheumatoid arthritis. Relation to anti-inflammatory treatment, sex, and menopause.
Als OS; Riis BJ; Gotfredsen A; Christiansen C; Deftos LJ
Acta Med Scand; 1986; 219(2):209-13. PubMed ID: 3485890
[TBL] [Abstract][Full Text] [Related]
4. The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects.
Nielsen HK; Thomsen K; Eriksen EF; Charles P; Storm T; Mosekilde L
Bone Miner; 1988 Apr; 4(1):105-13. PubMed ID: 3263890
[TBL] [Abstract][Full Text] [Related]
5. Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids.
Montecucco C; Caporali R; Caprotti P; Caprotti M; Notario A
J Rheumatol; 1992 Dec; 19(12):1895-900. PubMed ID: 1294736
[TBL] [Abstract][Full Text] [Related]
6. Serum osteocalcin concentrations in patients with rheumatoid arthritis.
Pietschmann P; Machold KP; Wolosczuk W; Smolen JS
Ann Rheum Dis; 1989 Aug; 48(8):654-7. PubMed ID: 2789500
[TBL] [Abstract][Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of parathyroid hormone and markers of bone metabolism in patients with rheumatoid arthritis. Relationship to disease activity and glucocorticoid treatment.
Jensen T; Hansen M; Madsen JC; Kollerup G; Stoltenberg M; Florescu A; Schwarz P
Scand J Clin Lab Invest; 2001; 61(6):491-501. PubMed ID: 11681539
[TBL] [Abstract][Full Text] [Related]
9. Increased serum osteocalcin levels in elderly females with vitamin D deficiency.
Pietschmann P; Woloszczuk W; Pietschmann H
Exp Clin Endocrinol; 1990 Apr; 95(2):275-8. PubMed ID: 2365024
[TBL] [Abstract][Full Text] [Related]
10. [Calcium regulating hormone in the pathological changes of bone in rheumatoid arthritis].
Ueyoshi A; Ota K; Okamoto Y; Shimizu E
Ryumachi; 1989 Oct; 29(5):349-57. PubMed ID: 2634883
[TBL] [Abstract][Full Text] [Related]
11. Long term administration of prostaglandin inhibitors in vivo fail to influence cartilage and bone mineral metabolism in the rat.
Boiskin I; Epstein S; Ismail F; Fallon MD; Levy W
Bone Miner; 1988 Apr; 4(1):27-36. PubMed ID: 3263891
[TBL] [Abstract][Full Text] [Related]
12. [ Serum osteocalcin in chronic polyarthritis in stage III].
Hermann E; Aeschlimann A; Müller W
Z Rheumatol; 1987; 46(3):129-31. PubMed ID: 3498276
[TBL] [Abstract][Full Text] [Related]
13. Decreased cellular activity and replicative capacity of osteoblastic cells isolated from the periarticular bone of rheumatoid arthritis patients compared with osteoarthritis patients.
Yudoh K; Matsuno H; Osada R; Nakazawa F; Katayama R; Kimura T
Arthritis Rheum; 2000 Oct; 43(10):2178-88. PubMed ID: 11037877
[TBL] [Abstract][Full Text] [Related]
14. [The study of parathyroid hormone and osteocalcin in patients with rheumatoid arthritis].
Ueyoshi A; Kiura Y; Ota K; Okamoto Y; Shimizu E
Ryumachi; 1987 Aug; 27(4):277-81. PubMed ID: 3502377
[No Abstract] [Full Text] [Related]
15. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
[TBL] [Abstract][Full Text] [Related]
16. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K
J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
[TBL] [Abstract][Full Text] [Related]
17. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
Lee SH; Huang TS; Hsieh SJ
Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
[TBL] [Abstract][Full Text] [Related]
18. Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment.
Coen G; Mazzaferro S; Costantini S; Ballanti P; Carrieri MP; Giordano R; Smacchi A; Sardella D; Bonucci E; Taggi F
Miner Electrolyte Metab; 1989; 15(5):295-302. PubMed ID: 2811788
[TBL] [Abstract][Full Text] [Related]
19. Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3.
Scheven BA; van der Veen MJ; Damen CA; Lafeber FP; Van Rijn HJ; Bijlsma JW; Duursma SA
J Bone Miner Res; 1995 Jun; 10(6):874-80. PubMed ID: 7572311
[TBL] [Abstract][Full Text] [Related]
20. Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls.
Laurberg TB; Frystyk J; Ellingsen T; Hansen IT; Jørgensen A; Tarp U; Hetland ML; Hørslev-Petersen K; Hornung N; Poulsen JH; Flyvbjerg A; Stengaard-Pedersen K
J Rheumatol; 2009 Sep; 36(9):1885-91. PubMed ID: 19684150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
